DelMar Pharmaceuticals CEO Saiid Zarrabian receives $939.0K in 2018

DelMar Pharmaceuticals reports 2018 executive compensation

By ExecPay News

Published: May 14, 2019

DelMar Pharmaceuticals reported fiscal year 2018 executive compensation information on May 14, 2019.
In 2018, four executives at DelMar Pharmaceuticals received on average a compensation package of $502.2K, a 4% increase compared to previous year.
Average pay of disclosed executives at DelMar Pharmaceuticals
Saiid Zarrabian, Chief Executive Officer, received $939K in total. 65.60% of Zarrabian's compensation, or $616K, was in option awards. Zarrabian also received $85.6K in bonus and $237.4K in salary.
Jeffrey Bacha, Chief Executive Officer, received a compensation package of $659.9K, which increased by 8% compared to previous year. 81.46% of the compensation package, or $537.6K, was in salary.
Scott Praill, Chief Financial Officer, earned $210K in 2018, a 45% decrease compared to previous year.
Dennis Brown, Chief Scientific Officer, received $200K in 2018, which decreases by 57% compared to 2017.
DelMar Pharmaceuticals' fiscal year ends on June 30.

Related executives

Saiid Zarrabian

DelMar Pharmaceuticals

Chief Executive Officer

Jeffrey Bacha

DelMar Pharmaceuticals

Chief Executive Officer

Dennis Brown

DelMar Pharmaceuticals

Chief Scientific Officer

Scott Praill

DelMar Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on May 14, 2019.